2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy
Open accessAbstract
EHRA), Heart Failure Association of the ESC
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The finding of nonsustained ventricular tachycardia is considered a significant risk factor for sudden death in patients with hypertrophic cardiomyopathy.
“The finding of nonsustained ventricular tachycardia is considered a significant risk factor for sudden death in patients with hypertrophic cardiomyopathy”
From 2017 ISHNE-HRS expert consensus statement on ambulatory ECG and external cardiac monitoring/telemetry (2017) · cites this paper as Elliott et al., 2014
Paroxysmal supraventricular arrhythmias (including AF) are observed in up to 38% of patients with HCM and are poorly tolerated, contributing to syncopal episodes or heart failure.
“Paroxysmal supraventricular arrhythmias (including AF) are observed in up to 38% of patients with HCM (Elliott et al., 2014;Gersh et al., 2011) and are poorly tolerated, contributing to syncopal episodes or heart failure.”
From 2017 ISHNE-HRS expert consensus statement on ambulatory ECG and external cardiac monitoring/telemetry (2017) · cites this paper as Elliott et al., 2014
While there is more experience with VKAs, there are no data to suggest that NOACs cannot be used in patients with hypertrophic cardiomyopathy.
“While there is more experience with VKAs, there are no data to suggest that NOACs cannot be used in these patients.845”
From 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS (2016) · cites this paper as [845]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
The citation lists haven’t been fetched yet
References 512 · Cited by 4,332
Research works printed but not linked: 10
- [7]7. Maron BJ, Mathenge R, Casey SA, Poliac LC, Longe TF. Clinical profile of hyper- trophic cardiomyopathy identified de novo in rural communities. J Am Coll Cardiol 1999;33:1590 -1595.
- [10]10. Maron BJ, Spirito P, Roman MJ, Paranicas M, Okin PM, Best LG, Lee ET, Devereux RB. Prevalence of hypertrophic cardiomyopathy in a population-based sample of American Indians aged 51 to 77 years (the Strong Heart Study). Am J Cardiol 2004;93:1510 -1514.
- [34]34. Richard P, Charron P, Carrier L, Ledeuil C, Cheav T, Pichereau C, Benaiche A, Isnard R, Dubourg O, Burban M, Gueffet JP, Millaire A, Desnos M, Schwartz K, Hainque B, Komajda M. Hypertrophic cardiomyopathy: distribution of disease genes, spectrum of mutations, and implications for a molecular diagnosis strategy. Circulation 2003;107:2227 -2232.
- [105]105. Burton H., Alberg C., Stewart A. Heart to Heart: Inherited Cardiovascular Conditions Services -A Needs Assessment and Service Review. PHG Fundation, UK, 2009.
- [187]187. Hershberger RE, Cowan J, Morales A, Siegfried JD. Progress with genetic cardiomy- opathies: screening, counseling, and testing in dilated, hypertrophic, and arrhyth- mogenic right ventricular dysplasia/cardiomyopathy. Circ Heart Fail 2009;2: 253-261.
- [204]204. Donnai D, Elles R. Integrated regional genetic services: current and future provi- sion. BMJ 2001;322:1048 -1052.
- [217]217. Barbosa CA, Castro CC, Avila LF, Parga F Jr., Hattem DM, Fernandez EA. Late en- hancement and myocardial perfusion in hypertrophic cardiomyopathy (compari- son between groups). Arq Bras Cardiol 2009;93:426 -25.
- [254]254. Blomstrom-Lundqvist C, Scheinman MM, Aliot EM, Alpert JS, Calkins H, Camm AJ, Campbell WB, Haines DE, Kuck KH, Lerman BB, Miller DD, Shaeffer CW, Stevenson WG, Tomaselli GF, Antman EM, Smith SC Jr., Alpert JS, Faxon DP, Fuster V, Gibbons RJ, Gregoratos G, Hiratzka LF, Hunt SA, Jacobs AK, Russell RO Jr., Priori SG, Blanc JJ, Budaj A, Burgos EF, Cowie M, Deckers JW, Garcia MA, Klein WW, Lekakis J, Lindahl B, Mazzotta G, Morais JC, Oto A, Smiseth O, Trappe HJ. ACC/AHA/ESC guidelines for the management of patients with supraventricular arrhythmias: executive summary. a report of the American college of cardiology/American heart association task force on practice guidelines and the European society of cardiology committee for practice guidelines (writing committee to develop guidelines for the management of patients with supraventri- cular arrhythmias) developed in collaboration with NASPE-Heart Rhythm Society. J Am Coll Cardiol 2003;42:1493 -1531.
- [280]280. Heric B, Lytle BW, Miller DP, Rosenkranz ER, Lever HM, Cosgrove DM. Surgical management of hypertrophic obstructive cardiomyopathy. Early and late results. J Thorac Cardiovasc Surg 1995;110:195 -206.
- [414]414. Kaski JP, Tome Esteban MT, Lowe M, Sporton S, Rees P, Deanfield JE, McKenna WJ, Elliott PM. Outcomes after implantable cardioverter-defibrillator treatment in chil- dren with hypertrophic cardiomyopathy. Heart 2007;93:372 -374.
- Authors
- Authors/Task Force members, Elliott, P. M., Anastasakis, A., Borger, M. A., Borggrefe, M., Cecchi, F., Charron, P., Hagege, A. A., Lafont, A., Limongelli, G., Mahrholdt, H., McKenna, W. J., Mogensen, J., Nihoyannopoulos, P., Nistri, S., Pieper, P. G., Pieske, B., Rapezzi, C., Rutten, F. H., Tillmanns, C., Watkins, H., Contributor, A., O'Mahony, C., ESC Committee for Practice Guidelines (CPG), Zamorano, J. L., Achenbach, S., Baumgartner, H., Bax, J. J., Bueno, H., Dean, V., Deaton, C., Erol, Ç., Fagard, R., Ferrari, R., Hasdai, D., Hoes, A. W., Kirchhof, P., Knuuti, J., Kolh, P., Lancellotti, P., Linhart, A., Nihoyannopoulos, P., Piepoli, M. F., Ponikowski, P., Sirnes, P. A., Tamargo, J. L., Tendera, M., Torbicki, A., Wijns, W., Windecker, S., Reviewers, D., Hasdai, D., Ponikowski, P., Achenbach, S., Alfonso, F., Basso, C., Cardim, N. M., Gimeno, J. R., Heymans, S., Holm, P. J., Keren, A., Kirchhof, P., Kolh, P., Lionis, C., Muneretto, C., Priori, S., Salvador, M. J., Wolpert, C., Zamorano, J. L., Frick, M., Aliyev, F., Komissarova, S., Mairesse, G., Smajić, E., Velchev, V., Antoniades, L., Linhart, A., Bundgaard, H., Heliö, T., Leenhardt, A., Katus, H. A., Efthymiadis, G., Sepp, R., Thor Gunnarsson, G., Carasso, S., Kerimkulova, A., Kamzola, G., Skouri, H., Eldirsi, G., Kavoliuniene, A., Felice, T., Michels, M., Hermann Haugaa, K., Lenarczyk, R., Brito, D., Apetrei, E., Bokheria, L., Lovic, D., Hatala, R., Garcia Pavía, P., Eriksson, M., Noble, S., Srbinovska, E., Özdemir, M., Nesukay, E., & Sekhri, N.
- Affiliations
- University of Liège (BE)
- The disclosure forms of the authors and reviewers are available on the ESC website www.escardio.org/guidelines
- ORCID
- Anastasakis, Aris
- Borger, Michael A.
- Cecchi, Franco
- Charron, Philippe
- Limongelli, Giuseppe
- Mahrholdt, Heiko
- McKenna, William J.
- Mogensen, Jens
- Nistri, Stefano
- Pieske, Burkert
- Rapezzi, Claudio
- Rutten, Frans H.
- Watkins, Hugh
- Baumgartner, Helmut
- Bax, Jeroen J.
- Bueno, Héctor
- Deaton, Christi
- Erol, Çetin
- Hoes, Arno W.
- Knuuti, Juhani
- Lancellotti, Patrizio
- Piepoli, Massimo F.
- Sirnes, Per Anton
- Tamargo, Juan Luis
- Torbicki, Adam
- Wijns, William
- Windecker, Stephan
- Cardim, Nuno Miguel
- Gimeno, Juan Ramón
- Heymans, Stephane
- Keren, Andre
- Lionis, Christos
- Muneretto, Claudio
- Priori, Silvia
- Smajić, Elnur
- Antoniades, Loizos
- Bundgaard, Henning
- Heliö, Tiina
- Leenhardt, Antoine
- Katus, Hugo A.
- Sepp, Róbert
- Carasso, Shemy
- Felice, Tiziana
- Lenarczyk, Radosław
- Noble, Stéphane
- Nesukay, Elena
- Venue
- European Heart Journal
- Publisher
- Oxford University Press (OUP)
- Published
- 2014-08-29
- Volume
- 35
- Issue
- 39
- Pages
- 2733-2779
- ISSN
- 0195-668X (ISSN-L)
- 1522-9645
- OpenAlex
- W2097618980
- Cited by
- 4,332
- References
- 512
- Citations by year
- 2026: 178 · 2025: 238 · 2024: 329 · 2023: 448 · 2022: 428 · 2021: 526 · 2020: 486 · 2019: 366 · 2018: 396 · 2017: 368 · 2016: 286 · 2015: 239 · 2014: 35 · 2013: 1
- FWCI
- 212.57
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- European Heart Journal (publishedVersion)
- PubMed (publishedVersion)
- Bern Open Repository and Information System (University of Bern) (submittedVersion, other-oa)
- Research Publications (Maastricht University) (submittedVersion, other-oa)
- Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) (submittedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Institutional Research Information System (Università degli Studi di Brescia) (submittedVersion)
- Archivio Istituzionale della Ricerca - Università degli Studi della Campania "Luigi Vanvitelli" (submittedVersion)
- Open Repository and Bibliography (University of Liège) (submittedVersion)
- University of Southern Denmark Research Portal (University of Southern Denmark) (submittedVersion)
- Institutional Research Information System University of Ferrara (University of Ferrara) (submittedVersion)
- Open Access CRIS of the University of Bern
- Funders
- Sociedad Española de Cardiología
- British Cardiovascular Society
- National Institute for Health and Care Research (NF-SI-0508-10235, NF-SI-0509-10230)
- Société Française de Cardiologie
- Hellenic Cardiological Society
- Türk Kardiyoloji Derneği
- Deutsche Gesellschaft für Kardiologie-Herz und Kreislaufforschung.
- Slovenská Kardiologická Spoločnost
- European Association of Cardiovascular Imaging
- Sociedade Portuguesa de Cardiologia
- Suomen Kardiologinen Seura
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiomyopathy and Myosin Studies
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Effects of Exercise
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Viral Infections and Immunology Research
- Keywords
- hypertrophic cardiomyopathy, diagnosis, management, guideline recommendations, left ventricular hypertrophy, heart failure
- MeSH terms
- Adult, Angina Pectoris, Arrhythmias, Cardiac, Cardiac Pacing, Artificial, Cardiomyopathy, Hypertrophic, Child, Delivery of Health Care, Diagnosis, Differential, Electrocardiography, Female, Genetic Counseling, Genetic Testing, Heart Failure, Heart Valve Diseases, Humans, Medical History Taking, Pedigree, Physical Examination, Pregnancy, Pregnancy Complications, Cardiovascular, Prenatal Care, Risk Factors, Sports Medicine, Syncope, Ventricular Outflow Obstruction, Preconception Care, Death, Sudden, Cardiac, Clinical Laboratory Techniques, Thoracic Surgical Procedures, Ablation Techniques, Cardiac Imaging Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
